ArticleBMC cancer2014

Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms.

Shiwei Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.